A Molecular Approach Designed to Limit the Replication of Mature DENV2 in Host Cells

Ummar Raheel1, Muhsin Jamal1, Najam Us Sahar Sadaf Zaidi1

  • 1Atta-ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST) , Islamabad, Pakistan .

Viral Immunology
|July 9, 2015
PubMed

Insights

This study demonstrates that small interfering RNA (siRNA) targeting the M region of mature Dengue virus type 2 (DENV2) effectively inhibits viral replication. Specifically, siRNA targeting the M protein reduced DENV2 by up to 85%, highlighting M as a promising target for RNA interference therapies.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • Dengue virus (DENV) is a significant arthropod-borne pathogen belonging to the Flaviviridae family, with a life cycle involving humans and mosquitoes.
  • Viral maturation involves the cleavage of the pre-membrane (prM) protein to the mature membrane (M) protein by furin, crucial for virus release from host cells.

Purpose of the Study:

  • To investigate the inhibition of mature Dengue virus isotype 2 (DENV2) using RNA interference (RNAi) in a Vero-81 cell line.
  • To identify specific viral targets for effective RNAi-mediated DENV2 inhibition.

Main Methods:

  • DENV2 was propagated and isolated from U937 cells, and maturation was confirmed by Western blot.
  • Vero-81 cells were transfected with synthetic small interfering RNAs (siRNAs) targeting DENV2, including those against the M protein.
  • Viral inhibition was assessed using focus-reduction assays, immunofluorescence assays (IFA), and real-time quantitative polymerase chain reaction (RT-qPCR).

Main Results:

  • Transfection with siRNA targeting the M protein (DENV2SsiRNA2) reduced DENV2 titer by up to 85% in focus reduction assays.
  • RT-qPCR confirmed a significant reduction in mature DENV2 RNA load.
  • IFA demonstrated decreased levels of cellular DENV2 following siRNA treatment.

Conclusions:

  • Mature DENV2 can be effectively inhibited by synthetic siRNAs targeting specific regions of the viral genome.
  • The M protein region of mature DENV2 is a highly effective target for RNAi-based inhibitory strategies.
  • This research validates M as a potential target for developing RNAi-based therapies against Dengue virus.